| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4255856 | Transplantation Proceedings | 2015 | 7 Pages |
Abstract
The molecular chimeric recipient mouse pre-T cell or HSC infusion reduced spleen T cells' response to allogeneic T cells in vitro and delayed cardiac allograft rejection in vivo. Pre-T cells have more advantages than HSCs on the prolongation of mouse cardiac allograft survival.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
L. Lu, G. Zhang, R. Li, Z. Zhao, W. Li, T. Liu, W. Fu,